Amphasys was founded in 2012 as a spin-off from Axetris AG, a company of the Leister group and focuses its activities in developing and marketing a novel, chip-based single cell analysis technology. The basic technology has been developed in 2004 in collaboration with the Swiss Federal Institute of Technology Lausanne (EPFL). In 2013 Amphasys was awarded with the most prestigious Swiss startup price by the W.A. de Vigier Foundation. Amphasys was also supported by the Albert Koechlin Foundation and certified by CTI Invest. Today, Amphasys is a speedily growing high tech company dedicated to reinventing single cell analysis and applying it to industrial production processes.
- Business Type:
- Industry Type:
- Monitoring and Testing - Laboratory Equipment
- Market Focus:
- Globally (various continents)
This company also provides solutions for other industrial applications.
Please, visit the following links for more info:
Amphasys‘ mission is to simplify, speed up and miniaturize complex cell analyses and move them to the point-of-use, which may be outside well-equipped research and analytical laboratories.
At Amphasys we are dedicated to supporting you to reach your analytical and quality control goals through the implementation of Impedance Flow Cytometry into your workflows.